MedPath

Pyrophosphate

Stannous Pyrophosphate

Approved
Approval ID

30046b6b-09ea-46b1-8e60-61c53e1e7282

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2012

Manufacturers
FDA

AnazaoHealth Corporation

DUNS: 011038762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pyrophosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51808-218
Product Classification
G
Generic Name
Pyrophosphate
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 13, 2012
FDA Product Classification

INGREDIENTS (2)

STANNOUS CHLORIDEInactive
Quantity: 3.5 mg in 1 1
Code: 1BQV3749L5
Classification: IACT
SODIUM PYROPHOSPHATEActive
Quantity: 27.6 mg in 1 1
Code: O352864B8Z
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Pyrophosphate - FDA Drug Approval Details